Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 4/20 | 0.59 |
| ▸ | CYP24A1 | Q07973 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.52 |
| ▸ | CYP17A1 | P05093 | 5/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20830319 | 1.00 | CYP19A1 (0.59) | CYP19A1CYP24A1KMT2AATMCYP26A1 | |
| SCHEMBL22241533 | 0.88 | CYP19A1 (0.58) | CYP19A1CYP24A1KMT2ACYP26A1CYP17A1 | |
| SCHEMBL19054885 | 0.88 | CYP19A1 (0.58) | CYP19A1CYP24A1KMT2ACYP26A1CYP17A1 | |
| SCHEMBL18516675 | 0.86 | CYP17A1 (0.50) | CYP19A1CYP24A1KMT2AATMCYP26A1 | |
| SCHEMBL19054886 | 0.86 | CYP19A1 (0.55) | CYP19A1CYP26A1CYP17A1SMN1; SMN2TDP1 | |
| SCHEMBL21419663 | 0.86 | CYP19A1 (0.56) | CYP19A1CYP24A1KMT2ACYP26A1CYP17A1 | |
| SCHEMBL19999185 | 0.86 | CYP17A1 (0.50) | CYP19A1CYP24A1KMT2ACYP26A1CYP17A1 | |
| SCHEMBL19054889 | 0.86 | CYP17A1 (0.50) | CYP19A1CYP24A1CYP17A1SMN1; SMN2TDP1 | |
| SCHEMBL20390011 | 0.85 | CYP19A1 (0.54) | CYP19A1CYP24A1KMT2ACYP26A1CYP17A1 | |
| SCHEMBL20390007 | 0.84 | CYP17A1 (0.46) | CYP19A1CYP24A1CYP26A1CYP17A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112368287-B | Tetracarboxylic dianhydride, polyimide precursor resin, polyimide precursor resin solution, polyimide solution and polyimide film | 引能仕株式会社 | 2024-01-09 | — | — | CN | disclosed |
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| WO-2021220919-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED METAL OXIDE MICROPARTICLES, METHOD FOR PRODUCING SURFACE-MODIFIED METAL OXIDE MICROPARTICLE DISPERSION, AND METHOD FOR PRODUCING SOLID PRODUCT | 東京応化工業株式会社 | 2021-11-04 | — | — | WO | disclosed |
| WO-2021220920-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED METAL OXIDE MICROPARTICLES, SURFACE-MODIFIED METAL OXIDE MICROPARTICLES, SURFACE-MODIFIED METAL OXIDE MICROPARTICLE DISPERSION, SOLID PRODUCT, METHOD FOR PRODUCING SURFACE-MODIFIED METAL OXIDE MICROPARTICLE DISPERSION, AND METHOD FOR PRODUCING SOLID PRODUCT | 東京応化工業株式会社 (JP) | 2021-11-04 | — | — | WO | disclosed |
| US-11142629-B2 | Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| US-11136435-B2 | Method for producing polyimide film, polyimide film, polyamic acid solution, and photosensitive composition | ENEOS CORPORATION (JP) | 2021-10-05 | — | — | US | disclosed |
| US-11111397-B2 | Silica-based film-forming composition, method of producing substrate including silica-based film, and additive added to silica-based film-forming composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-09-07 | — | — | US | disclosed |
| US-10954340-B2 | Polyimide precursor composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-03-23 | — | — | US | disclosed |
| CN-112368287-A | Tetracarboxylic dianhydride, polyimide precursor resin, polyimide precursor resin solution, polyimide solution, and polyimide film | 引能仕株式会社 | 2021-02-12 | — | — | CN | disclosed |
| US-20180086717-A1 | HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
| EP-3275940-A1 | ENERGY-SENSITIVE RESIN COMPOSITION | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2018-01-31 | — | — | EP | disclosed |
| US-20170327631-A1 | CURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| US-20170327631-A1 | CURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| EP-3228641-A1 | CURABLE COMPOSITION | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2017-10-11 | — | — | EP | disclosed |
| US-20170247334-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-08-31 | — | — | US | disclosed |
| US-20170247334-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-08-31 | — | — | US | disclosed |
| EP-3184511-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2017-06-28 | — | — | EP | disclosed |
| WO-2017026448-A1 | POLYIMIDE PRECURSOR COMPOSITION | 東京応化工業株式会社 | 2017-02-16 | — | — | WO | disclosed |
| WO-2016158679-A1 | ENERGY-SENSITIVE RESIN COMPOSITION | 東京応化工業株式会社 | 2016-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086717-A1 | HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT | SLC9A2, SLC9A1, NHERF1 | CYP19A1 820/4885CYP24A1 3411/4885KMT2A 1420/4885 |
| US-20170247334-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | FASN, SLC27A1, SLC27A2 | CYP19A1 1211/4885CYP24A1 1784/4885KMT2A 1187/4885 |
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | MSMO1, RIOK1, ME1 | CYP19A1 396/4885CYP24A1 2215/4885KMT2A 1027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.